Company: BSX
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000885725-25-000011
Chunk: 186

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 186
---
 Code. Such options may be exercised only to the extent of accumulated payroll deductions at the end of the offering period, at a purchase price equal to 85 percent of the fair market value of our common stock at the beginning or end of each offering period, whichever is less. As of December 31, 2024, there were approximately 6 million shares available for future issuance under the employee stock purchase plan.Information related to shares issued or to be issued in connection with the employee stock purchase plan based on employee contributions and the range of purchase prices is as follows:Year Ended December 31,202420232022Shares issued or to be issued (in thousands)2,409 2,623 2,850 Range of purchase prices$49.16 -$64.95 $39.11 -$45.51 $31.68 -$32.31 Expense recognized (in millions)$34 $29 $28 We use the Black-Scholes option-pricing model to calculate the grant-date fair value of shares issued under the employee stock purchase plan. We recognize expense related to shares purchased through the employee stock purchase plan ratably over the offering period.

112

NOTE L – WEIGHTED AVERAGE SHARES OUTSTANDINGYear Ended December 31,(in millions)202420232022Weighted average shares outstanding - basic1,471.5 1,453.0 1,430.5 Net effect of common stock equivalents14.4 10.6 9.2 Weighted average shares outstanding - diluted1,485.9 1,463.5 1,439.7 The following securities were excluded from the calculation of weighted average shares outstanding - diluted because their effect in the periods presented below would have been antidilutive:Year Ended December 31,(in millions)202420232022Stock options outstanding(1)—06MCPS(2)—1024(1) Represents stock options outstanding pursuant to our employee stock-based compensation plans with exercise prices that were greater than the average fair market value of our common stock for the related periods.(2) Represents common stock issuable upon the conversion of our MCPS. Refer to Note J – Stockholders' Equity for additional information.We base Net income (loss) per common share - diluted upon the weighted-average number of common shares and common stock equivalents outstanding during each year. Potential common stock equivalents are determined using the treasury stock method. We exclude stock options, stock awards and, prior to the Mandatory Conversion